Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma
Clinical trial NCT05718778 · UNKNOWN
Trial details
- NCT number
- NCT05718778
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2024-03-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.